These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32152974)

  • 1. Formulation and Characterization of Antithrombin Perfluorocarbon Nanoparticles.
    Wilson AJ; Zhou Q; Vargas I; Palekar R; Grabau R; Pan H; Wickline SA
    Methods Mol Biol; 2020; 2118():111-120. PubMed ID: 32152974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombin nanoparticles inhibit stent thrombosis in ex vivo static and flow models.
    Palekar RU; Vemuri C; Marsh JN; Arif B; Wickline SA
    J Vasc Surg; 2016 Nov; 64(5):1459-1467. PubMed ID: 26482989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of antithrombin III-independent thrombin inhibitors and heparin on fibrin accretion onto fibrin-coated polyethylene.
    Rubens FD; Weitz JI; Brash JL; Kinlough-Rathbone RL
    Thromb Haemost; 1993 Feb; 69(2):130-4. PubMed ID: 8456425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombin inhibitors and anti-coagulants on thrombin-induced embolisation in rabbit cranial vasculature.
    Liu JT; Paul W; Emerson M; Cicala C; Page CP
    Eur J Pharmacol; 1994 Oct; 264(2):183-90. PubMed ID: 7851481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.
    Weitz JI; Hudoba M; Massel D; Maraganore J; Hirsh J
    J Clin Invest; 1990 Aug; 86(2):385-91. PubMed ID: 2384594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual compatibility of bivalirudin with selected drugs.
    Hartman CA; Faria CE; Mago K
    Am J Health Syst Pharm; 2004 Sep; 61(17):1774, 1776. PubMed ID: 15462247
    [No Abstract]   [Full Text] [Related]  

  • 7. Bivalirudin: a review of the pharmacology and clinical application.
    Van De Car DA; Rao SV; Ohman EM
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1673-81. PubMed ID: 21108549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Thrombin With PPACK-Nanoparticles Restores Disrupted Endothelial Barriers and Attenuates Thrombotic Risk in Experimental Atherosclerosis.
    Palekar RU; Jallouk AP; Myerson JW; Pan H; Wickline SA
    Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):446-55. PubMed ID: 26769047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethyl ketone.
    Hanson SR; Harker LA
    Proc Natl Acad Sci U S A; 1988 May; 85(9):3184-8. PubMed ID: 3362867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and characterization of novel hirulog variants with antithrombin and antiplatelet activities.
    Yu Z; Huang Y; Wang Y; Dai C; Dong M; Liu Z; Yu S; Hu J; Dai Q
    Protein Pept Lett; 2014; 21(1):69-74. PubMed ID: 24354772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The acceleratory effect of thrombin on fibrin clot assembly.
    Mosesson MW; Kaminski M
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):475-8. PubMed ID: 2133225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel uses for current and future direct thrombin inhibitors: focus on ximelagatran and bivalirudin.
    Kalus JS; Caron MF
    Expert Opin Investig Drugs; 2004 May; 13(5):465-77. PubMed ID: 15155122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for thrombin enhancement of fibrin polymerization that is independent of its catalytic activity.
    Kaminski M; Siebenlist KR; Mosesson MW
    J Lab Clin Med; 1991 Mar; 117(3):218-25. PubMed ID: 2002278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct thrombin inhibitor-bivalirudin functionalized plasma polymerized allylamine coating for improved biocompatibility of vascular devices.
    Yang Z; Tu Q; Maitz MF; Zhou S; Wang J; Huang N
    Biomaterials; 2012 Nov; 33(32):7959-71. PubMed ID: 22877639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antithrombotic effect of low molecular weight synthetic thrombin inhibitors, argatroban and PPACK, on He-Ne laser-induced thrombosis in rat mesenteric microvessels.
    Yamashita T; Yamamoto J; Sasaki Y; Matsuoka A
    Thromb Res; 1993 Jan; 69(1):93-100. PubMed ID: 8465278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bivalirudin: a new promising direct antithrombin.
    Bhambhani A; Meier B
    Indian Heart J; 2007; 59(3):288-94. PubMed ID: 19124943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct features of bivalent direct thrombin inhibitors, hirudin and bivalirudin, revealed by clot waveform analysis and enzyme kinetics in coagulation assays.
    Wakui M; Fujimori Y; Nakamura S; Kondo Y; Kuroda Y; Oka S; Nakagawa T; Katagiri H; Murata M
    J Clin Pathol; 2019 Dec; 72(12):817-824. PubMed ID: 31366633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low plasma fibrinogen levels with the Clauss method during anticoagulation with bivalirudin.
    Molinaro RJ; Szlam F; Levy JH; Fantz CR; Tanaka KA
    Anesthesiology; 2008 Jul; 109(1):160-1. PubMed ID: 18580197
    [No Abstract]   [Full Text] [Related]  

  • 19. Immobilization of the direct thrombin inhibitor-bivalirudin on 316L stainless steel via polydopamine and the resulting effects on hemocompatibility in vitro.
    Lu L; Li QL; Maitz MF; Chen JL; Huang N
    J Biomed Mater Res A; 2012 Sep; 100(9):2421-30. PubMed ID: 22566466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis.
    Myerson J; He L; Lanza G; Tollefsen D; Wickline S
    J Thromb Haemost; 2011 Jul; 9(7):1292-300. PubMed ID: 21605330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.